Explore UAB

University of Alabama at Birmingham

Gorgas Case 2025-7

Universidad Peruana Cayetano Heredia
The following patient was seen on the inpatient ward of Cayetano Heredia Hospital (HCH) in Lima by the 2025 Gorgas Course participants.
Image for Case 2025-7

History: A 52-year-old male patient presented to the outpatient clinic in HCH with a seven-year history of swelling, changes in coloration, and discomfort while walking on the right foot. The patient reports that seven years before admission, during a trip to the jungle (Juanjui, San Martin), after playing soccer barefoot, he noticed a small laceration on the sole of his right foot. He did not experience significant discomfort; however, the lesion persisted. Five years before admission, the lesion progressively increased in volume, became edematous, and adopted a tumor-like appearance. Symptoms continued, and two years before admission, he noticed that the tumor-like lesion acquired a dark-brown discoloration and began intermittently discharging white-to-yellowish granules.
Additionally, he noted that the lesion expanded from the sole to the medial aspect and ankle of the right foot. Symptoms persisted, and six months before admission, the patient noticed right inguinal lymphadenopathy and subjective fever. The lesion impeded him from walking, so he presented to HCH for further workup and management.

Epidemiology: He was born in Bagua, Amazonas but moved to Lima 25 years before admission. He previously worked as a rice harvester before coming to Lima and, since moving, has been a handcrafter. Seven years ago, he traveled to Juanjui, San Martín, where he played soccer barefoot. He has not traveled to the jungle ever since.

Physical Examination on admission: BP: 120/70 mmHg; RR: 18; HR: 77; T: 26.8°C, Sp02 99% on room air. He was in regular general condition. He presented with a tumor-like lesion on the right foot with grain discharge (Image A), edema with fovea extending from the ankle to the foot (Image B), and a single enlarged right inguinal lymph node measuring 2x1 cm, mobile, and non-tender to palpation. His respiratory and abdominal examinations were non-contributory. The musculoskeletal evaluation showed muscle contraction on the inner part of the thigh with preserved strength in the right lower limb. Neurologically, he was alert with a Glasgow Coma Scale score of 15/15, without focal or meningeal signs. The rest of the exam was normal.

Laboratory: Hb 10.7 g/dL, MCV 88.2 fL, MCH 28.4 pg, WBC 7.46 ×10³/µL (Neut 5.33 ×10³/µL, Lymph 1.4 ×10³/µL, Mono 0.46 ×10³/µL, Eos 0.20 ×10³/µL, Baso 0.07 ×10³/µL), Plt 506 ×10³/µL, Glu 93 mg/dL, Urea 35 mg/dL, Cr 0.84 mg/dL, AST 17 U/L, ALT 13 U/L, T. Bili 0.41 mg/dL (D. Bili 0.16 mg/dL, I. Bili 0.25 mg/dL). Serology tests for HIV, HTLV, HBsAg, and RPR were negative.

Imaging: A foot MRI revealed lytic lesions in the tarsus and metatarsus and a soft tissue abscess in the Achilles heel and foot sole (Image C).

Microbiology: Gram stain from the grains revealed the following structures (Image D) and culture revealed the following colonies (Image E).

UPCH Case Editors: Carlos Seas, Course  Director / Mario Suito, Associate Coordinator 
UAB Case Editors: David O. Freedman, Course Director Emeritus / German Henostroza, Course Director


Diagnosis:
 Actinomycetoma caused by Nocardia farcinica

Discussion: Gram stain from the grains revealed gram-positive 0.5-1-μm-wide filamentous structures compatible with an agent of actinomycetoma, later identified through MALDI-TOF as Nocardia farcinica. Mycetoma (also known as Madura foot) is the most common worldwide subcutaneous tropical infection first described in 1842 in Madras, India. The latest reports indicate over 8,700 cases globally, with approximately 127 new cases per year across 23 countries, the most affected being India, Sudan, and Mexico (1). Males are disproportionately affected (6:1), and the disease primarily occurs in adolescents and young adults under 40 (2).

Actinomycetoma, which predominates in the Americas, is caused by various species of aerobic filamentous bacteria, including Nocardia, Actinomadura, and Streptomyces. Eumycetoma, by contrast, is a fungal infection most commonly caused by Madurella mycetomatis and is more prevalent in Africa and Asia (3).

Clinically, mycetoma is characterized by tumor-like swellings, sinus tracts, and grain discharge. The lower extremities are affected in 80% of cases. While the disease is usually localized, actinomycetomas more frequently extend deeper into bones and joints than eumycetomas. Actinomycetoma grains tend to be smaller than those of eumycetomas, are composed of filamentous bacteria, and function as biofilms, limiting antibiotic penetration. Actinomycetoma grains are typically white or pale yellow, except for those caused by Actinomadura pelletieri, which appear red to pink. Eumycetoma grains, on the other hand, are usually black, brown, yellow, or white, depending on the causative fungal species. In this case, the presence of white granules ruled out Madurella mycetomatis, which typically produces black granules (4).

Diagnosis is primarily clinical, based on the triad of swelling, sinus tracts, and grain drainage. Imaging assesses disease extent, while culture and molecular methods confirm the causative organism (5). Grains, either spontaneously extruded or aspirated, can be cultured on blood or Sabouraud agar, and drug susceptibility testing is recommended for all cases (6, 7). Among Nocardia species, the most common causative agent is Nocardia brasiliensis. A recent study from China found Nocardia farcinica the most common species among all nocardiosis cases and was, as most Nocardia species, susceptible to TMP-SMX, Amikacin, and Linezolid (8).

Combination antibiotic therapy is recommended to prevent antimicrobial resistance. Treatment typically involves a trimethoprim-sulfamethoxazole (TMP-SMX) backbone combined with an aminoglycoside, rifampin, or dapsone for 6–24 months. While surgery is commonly used for eumycetomas, it is less frequently required for actinomycetoma due to the high effectiveness of medical therapy (3, 9). Our patient was started on a combination regimen of TMP-SMX and amikacin.

References
1. van de Sande WWJ (2013) Global Burden of Human Mycetoma: A Systematic Review and Meta-analysis. PLoS Negl Trop Dis 7(11): e2550. doi:10.1371/ journal.pntd.0002550
2. Zijlstra EE, van de Sande WWJ, Welsh O, Mahgoub ES, Goodfellow M, Fahal AH. Mycetoma: a unique neglected tropical disease. Lancet Infect Dis. 2016 Jan;16(1):100-112.
3. Verma P, Jha A. Mycetoma: reviewing a neglected disease. Clin Exp Dermatol. 2019 Mar;44(2):123-129.
4. Emmanuel P, Dumre SP, John S, Karbwang J, Hirayama K. Mycetoma: a clinical dilemma in resource limited settings. Ann Clin Microbiol Antimicrob. 2018 Aug 10;17(1):35.
5. Ahmed AA, van de Sande W, Fahal AH. Mycetoma laboratory diagnosis: Review article. PLoS Negl Trop Dis. 2017 Aug;11(8):e0005638.
6. Siddig EE, Mhmoud NA, Bakhiet SM, Abdallah OB, Mekki SO, El Dawi NI, et al. (2019) The Accuracy of Histopathological and Cytopathological Techniques in the Identification of the Mycetoma Causative Agents. PLoS Negl Trop Dis 13(8): e0007056.
https://doi.org/10.1371/journal.pntd.0007056 7. Siddig EE, El Had Bakhait O, El nour Hussein Bahar M, Ahmed ES, Bakhiet SM, Ali MM, Abdallah OB, Hassan RA, Verbon A, van de Sande WWJ, Fahal AH. Ultrasound-guided fine-needle aspiration cytology significantly improved mycetoma diagnosis. J Eur Acad Dermatol Venereol. 2022;36(10):1845–50. doi:10.1111/jdv.18363.
8. Wang H, Zhu Y, Cui Q, Wu W, Li G, Chen D, et al. Epidemiology and Antimicrobial Resistance Profiles of the Nocardia Species in China, 2009 to 2021. Prokesch BC, editor. Microbiol Spectr. 27 April 2022;10(2):e01560-21.
9. Welsh O, Vera-Cabrera L, Welsh E, Salinas MC. Actinomycetoma and advances in its treatment. Clin Dermatol 2012; 30: 372–381.